Adira Labs Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 3 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 1847.50%
(FY 2023)
- Profit -85.03%
(FY 2023)
- Ebitda -52.05%
(FY 2023)
- Net Worth -274.44%
(FY 2023)
- Total Assets 14237.52%
(FY 2023)
About Adira Labs
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Raghav Mittal and Piyush Mittal serve as directors at the Company.
- CIN/LLPIN
U24299UP2021PTC148210
- Company No.
148210
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Jul 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Ghaziabad, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Adira Labs?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Raghav Mittal  | Director | 02-Jul-2021 | Current |
| Piyush Mittal | Director | 02-Jul-2021 | Current |
Financial Performance and Corporate Structure Insights of Adira Labs.
Adira Labs Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 1847.5% increase. The company also saw a substantial fall in profitability, with a 85.03% decrease in profit. The company's net worth observed a substantial decline by a decrease of 274.44%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Adira Labs?
Unlock access to Adira Labs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
N.G. Electro Products Private LimitedActive 18 years 4 monthsRaghav Mittal and Piyush Mittal are mutual person
Flurry Foods Private LimitedActive 17 years 11 monthsRaghav Mittal and Piyush Mittal are mutual person
- Alkomex Pharma Private LimitedActive 7 years 8 months
Raghav Mittal and Piyush Mittal are mutual person
- Vayu Special Chem Private LimitedActive 11 months 14 days
Raghav Mittal and Piyush Mittal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Adira Labs?
Unlock and access historical data on people associated with Adira Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Adira Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Adira Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
